Accent Therapeutics and Ipsen Signed an Exclusive Worldwide Collaboration, Targeting the RNA Modifying Protein, METTL3 Portfolio News / Karina Tin October 18, 2021 Accent Therapeutics and Ipsen Signed an Exclusive Worldwide Collaboration, Targeting the RNA Modifying Protein, METTL3 Read More »
Baylor College of Medicine Presents eFFECTOR Therapeutics-Backed Preclinical Data Supporting Development of Zotatifin in Triple-Negative Breast Cancer at 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Portfolio News / Karina Tin October 7, 2021 Baylor College of Medicine Presents eFFECTOR Therapeutics-Backed Preclinical Data Supporting Development of Zotatifin in Triple-Negative Breast Cancer at 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Read More »
ORIC Pharmaceuticals Presents Initial Clinical Data from Phase 1b Trial of ORIC-101 in Combination with Enzalutamide and Preclinical Data on ORIC-114 at AACR-NCI-EORTC Portfolio News / Karina Tin October 7, 2021 ORIC Pharmaceuticals Presents Initial Clinical Data from Phase 1b Trial of ORIC-101 in Combination with Enzalutamide and Preclinical Data on ORIC-114 at AACR-NCI-EORTC Read More »
Surrozen Presented Data Supporting Potential of SZN-1326 at the 2021 United European Gastroenterology Week Portfolio News / Karina Tin October 5, 2021 Surrozen Presented Data Supporting Potential of SZN-1326 at the 2021 United European Gastroenterology Week Read More »
RAPT Therapeutics Announces Late-Breaking Oral Presentation of Positive Results from Phase 1B Trial of RPT193 at the 30th European Academy of Dermatology and Venereology Congress Portfolio News / Karina Tin September 30, 2021 RAPT Therapeutics Announces Late-Breaking Oral Presentation of Positive Results from Phase 1B Trial of RPT193 at the 30th European Academy of Dermatology and Venereology Congress Read More »
Ribon Therapeutics Named a “Fierce 15” Biotech Company by Fierce Biotech Portfolio News / Karina Tin September 27, 2021 Ribon Therapeutics Named a “Fierce 15” Biotech Company by Fierce Biotech Read More »
Hexagon Bio Raises $61 Million to Advance Novel Small-Molecule Medicines Mined from Microbial Genomes Portfolio News / Karina Tin September 22, 2021 Hexagon Bio Raises $61 Million to Advance Novel Small-Molecule Medicines Mined from Microbial Genomes Read More »
ORIC Pharmaceuticals Announces Update on ORIC-533, a Highly Potent, Orally Bioavailable Small Molecule CD73 Inhibitor Portfolio News / Karina Tin September 21, 2021 ORIC Pharmaceuticals Announces Update on ORIC-533, a Highly Potent, Orally Bioavailable Small Molecule CD73 Inhibitor Read More »
NGM Bio Presents Preliminary Findings from Ongoing Phase 1a/1b Dose Escalation Study of NGM120 in Patients with Advanced Solid Tumors at the ESMO Virtual Congress 2021 Portfolio News / Karina Tin September 16, 2021 NGM Bio Presents Preliminary Findings from Ongoing Phase 1a/1b Dose Escalation Study of NGM120 in Patients with Advanced Solid Tumors at the ESMO Virtual Congress 2021 Read More »
Tenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates Portfolio News / Karina Tin September 8, 2021 Tenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates Read More »